Australia markets closed

Lumos Pharma, Inc. (LUMO)

NasdaqGM - NasdaqGM Delayed price. Currency in USD
Add to watchlist
3.8000-0.0100 (-0.26%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 30.87M
Enterprise value 14.52M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)20.70
Price/book (mrq)3.00
Enterprise value/revenue 9.77
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.36
52-week change 316.56%
S&P500 52-week change 320.52%
52-week high 34.5500
52-week low 31.3700
50-day moving average 32.4124
200-day moving average 32.7188

Share statistics

Avg vol (3-month) 378.71k
Avg vol (10-day) 3208.2k
Shares outstanding 58.12M
Implied shares outstanding 68.12M
Float 85.32M
% held by insiders 134.80%
% held by institutions 125.69%
Shares short (15 Aug 2024) 4462.3k
Short ratio (15 Aug 2024) 411.26
Short % of float (15 Aug 2024) 48.07%
Short % of shares outstanding (15 Aug 2024) 45.69%
Shares short (prior month 15 July 2024) 4361.5k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 319 Mar 2020
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)30 June 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-1,603.07%

Management effectiveness

Return on assets (ttm)-60.50%
Return on equity (ttm)-132.56%

Income statement

Revenue (ttm)1.49M
Revenue per share (ttm)0.18
Quarterly revenue growth (yoy)-7.40%
Gross profit (ttm)N/A
EBITDA -37.59M
Net income avi to common (ttm)-35.75M
Diluted EPS (ttm)-4.4200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)16.8M
Total cash per share (mrq)2.07
Total debt (mrq)449k
Total debt/equity (mrq)4.37%
Current ratio (mrq)4.23
Book value per share (mrq)1.26

Cash flow statement

Operating cash flow (ttm)-34.49M
Levered free cash flow (ttm)-22.13M